Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Halberd Corp HALB

Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It is also developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It has two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its Sequential Dialysis Technique is a methodology that physically removes the pathophysiologic basis of the disease, eliminating it without side effects. The Company’s wholly owned subsidiary is Alaric Corporation.


OTCPK:HALB - Post by User

<< Previous
Bullboard Posts
Next >>
Post by AveragePennyon Jan 05, 2022 10:21am
53 Views
Post# 34284850

Halberd Corporation Now an Official US Government Contractor

Halberd Corporation Now an Official US Government Contractor

JACKSON CENTER, PA / ACCESSWIRE / January 5, 2022 / Halberd Corporation (OTC PINK:HALB) is now registered with the Federal Government's System for Award Management allowing Halberd to bid on Federal contracts and conduct business with the Federal government in the areas of Research and Development in Biotechnology, and Food (Health) Supplement Stores. This opens the door to Halberd to provide products and services to members of the military and various government agencies who may benefit from Halberd's technology to address various neurodegenerative diseases such as PTSD, Chronic Traumatic Encephalopathy (CTE), Epilepsy and many other diseases.

William A. Hartman, Chairman, President, and CEO, stated, "Halberd's patented extracorporeal technologies permit us to advance the potential treatment of neurodegenerative diseases beyond anybody else in the industry. The magnitude of the health problems associated with neurodegenerative diseases in the USA alone is far larger than is generally known:

  • PTSD/CTE-24.5 million (men at 6% and women at 8% of population per the National Center for PTSD)
  • Alzheimer's Disease-6.2 million (40 million worldwide)
  • Parkinson's Disease-1.0 million
  • Multiple Sclerosis-400,000
  • Lou Gehrig's Disease-30,000
  • Huntington's Disease-30,000
  • Epilepsy-3.4 million
  • Total-35.6 million

https://www.accesswire.com/681030/halberd-corporation-now-an-official-us-government-contractor

<< Previous
Bullboard Posts
Next >>